MedPath

DERMFREE HELPS WITH NAGELPILZ

84010-097

Approved
Approval ID

32c94b5d-b77c-ad01-e063-6394a90a1cba

Product Type

HUMAN OTC DRUG LABEL

Effective Date

Apr 14, 2025

Manufacturers
FDA

Jiangxi Hemei Pharmaceutical Co., Ltd

DUNS: 724892056

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Tolnaftate 1% Helps With Nagelpilz

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code84010-097
Application NumberM005
Product Classification
M
Marketing Category
C200263
G
Generic Name
Tolnaftate 1% Helps With Nagelpilz
Product Specifications
Route of AdministrationTOPICAL
Effective DateApril 14, 2025
FDA Product Classification

INGREDIENTS (7)

PSEUDOLARIX AMABILIS BARKInactive
Code: 49G13A93VE
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
HYDRACRYLIC ACIDInactive
Code: C4ZF6XLD2X
Classification: IACT
TOLNAFTATEActive
Quantity: 1 g in 100 mL
Code: 06KB629TKV
Classification: ACTIB
GLYCERINInactive
Code: PDC6A3C0OX
Classification: IACT
RESORCINOLInactive
Code: YUL4LO94HK
Classification: IACT
EUPHORBIA HIRTA WHOLEInactive
Code: L13YF113GN
Classification: IACT

Drug Labeling Information

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

LOINC: 51945-4Updated: 4/15/2025

INDICATIONS & USAGE SECTION

LOINC: 34067-9Updated: 4/15/2025

OTC - ACTIVE INGREDIENT SECTION

LOINC: 55106-9Updated: 4/15/2025

OTC - PURPOSE SECTION

LOINC: 55105-1Updated: 4/15/2025

WARNINGS SECTION

LOINC: 34071-1Updated: 4/15/2025

OTC - DO NOT USE SECTION

LOINC: 50570-1Updated: 4/15/2025

OTC - WHEN USING SECTION

LOINC: 50567-7Updated: 4/15/2025

OTC - STOP USE SECTION

LOINC: 50566-9Updated: 4/15/2025

OTC - ASK DOCTOR SECTION

LOINC: 50569-3Updated: 4/15/2025

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

LOINC: 50565-1Updated: 4/15/2025

DOSAGE & ADMINISTRATION SECTION

LOINC: 34068-7Updated: 4/15/2025

INACTIVE INGREDIENT SECTION

LOINC: 51727-6Updated: 4/15/2025

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

DERMFREE HELPS WITH NAGELPILZ - FDA Drug Approval Details